Choroidal neovascularization secondary to pseudoxanthoma elasticum treated with ranibizumab: A report of two cases
| Autor: | A. González-Gómez, M.J. Morillo, A.B. González-Escobar, J.M. García-Campos |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Abstract case genetic structures business.industry General Medicine Pseudoxanthoma elasticum medicine.disease eye diseases Angioid streaks Choroidal neovascularization Ophthalmology medicine sense organs Working age medicine.symptom Intravitreal ranibizumab Ranibizumab business medicine.drug |
| Zdroj: | Archivos de la Sociedad Española de Oftalmología (English Edition). 87:153-156 |
| ISSN: | 2173-5794 |
| DOI: | 10.1016/j.oftale.2012.09.004 |
| Popis: | Case report We report two cases of pseudoxanthoma elasticum with angioid streaks and choroidal neovascularization (CNV) in both eyes. Intravitreal ranibizumab (Lucentis) was administered with successful results in both cases. Discussion CNV has been reported to occur in 72–86% of patients with angioid streaks. Although uncommon, the impact of CNV is important because it tends to affect people of working age. Based on the effectiveness of ranibizumab in other secondary CNVs, we decided to use it in our patients, observing the functional and anatomical improvement. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect